A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants

NCT03891108 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: BMS-986231 Formulation A
DRUG: BMS-986231 Formulation B
DRUG: BMS-986231 Formulation C
DRUG: BMS-986231 Formulation D

Sponsor

Bristol-Myers Squibb